News - Page 4 - Psychedelic Alpha

Read more about the article A Crucible of Academia, Psychedelics, and Religion: Psychedelic Intersections 2025 at The Harvard Divinity School

A Crucible of Academia, Psychedelics, and Religion: Psychedelic Intersections 2025 at The Harvard Divinity School

Post published:February 24, 2025
Post category:News

Read more about the article UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in Parliamentary Report

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in Parliamentary Report

Post published:February 21, 2025
Post category:Analysis News

Read more about the article MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

Post published:February 19, 2025
Post category:Interviews Pα+

Read more about the article Opinions: PrEP’s Rollout Offers a Roadmap for Prescription Psychedelics

Opinions: PrEP’s Rollout Offers a Roadmap for Prescription Psychedelics

Post published:February 18, 2025
Post category:Opinions

Read more about the article Magic Mushrooms Meet Corporate Conspiracy: Steve Hely on Adult Swim’s Common Side Effects

Magic Mushrooms Meet Corporate Conspiracy: Steve Hely on Adult Swim’s Common Side Effects

Post published:February 17, 2025
Post category:Interviews

Read more about the article Pα+ Psychedelic Bulletin #188: Q4’24 Lobbying Update; Virginia Lawmakers Question Purpose, Precedent of Compass Bill; VA Loses Psychedelics Champion; GH Discusses Lack of Placebo Effect

Pα+ Psychedelic Bulletin #188: Q4’24 Lobbying Update; Virginia Lawmakers Question Purpose, Precedent of Compass Bill; VA Loses Psychedelics Champion; GH Discusses Lack of Placebo Effect

Post published:February 14, 2025
Post category:Psychedelic Bulletin Pα+

Read more about the article Psychedelic Funding, Public Markets, and M&A in 2024

Psychedelic Funding, Public Markets, and M&A in 2024

Post published:February 12, 2025
Post category:2024 Year in Review Analysis

Read more about the article Ketamine on the Edge: Mindbloom’s At-Home Injections Spark Debate; UK Eyes Tougher Laws; DEA to Regulate Telehealth Prescribing; Spravato Sales Top $1bn

Ketamine on the Edge: Mindbloom’s At-Home Injections Spark Debate; UK Eyes Tougher Laws; DEA to Regulate Telehealth Prescribing; Spravato Sales Top $1bn

Post published:February 10, 2025
Post category:Analysis News Pα+

Read more about the article Pα+ Psychedelic Bulletin #187: NYT Article Reignites MDMA Rejection Blame Game; FDA “Wanted to Approve” MDMA, MindMed Exec Says; GH’s Data and RFK Jr. Confirmation Send Psychedelics Stocks Soaring

Pα+ Psychedelic Bulletin #187: NYT Article Reignites MDMA Rejection Blame Game; FDA “Wanted to Approve” MDMA, MindMed Exec Says; GH’s Data and RFK Jr. Confirmation Send Psychedelics Stocks Soaring

Post published:February 7, 2025
Post category:Psychedelic Bulletin Pα+

Read more about the article GH Research Reports Strong Phase 2b Results for 5-MeO-DMT in Treatment-Resistant Depression

GH Research Reports Strong Phase 2b Results for 5-MeO-DMT in Treatment-Resistant Depression

Post published:February 3, 2025
Post category:Analysis News Pα+

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.